| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$1,622 |
Appendix 3Y - Brad Welsh
|
28 Apr 2026 9:36AM |
$0.004 |
$0.004 |
risen by
14.29%
|
|
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$231 |
Further Benchmark Results Prove Infrastructure Cost Savings
|
28 Apr 2026 9:36AM |
$0.715 |
$0.720 |
risen by
0.70%
|
|
FTI - Price-sensitive ASX Announcement
Full Release
Key Points
- FTI's Nol8 FPGA appliance can replace up to 60,000 CPUs for AI workloads.
- Nol8 delivers AI-grade data processing at significantly lower costs and footprint.
- Annual operating cost of the Nol8 is under A$37,000 compared to A$4.5m for CPUs.
- Further benchmark testing confirms infrastructure cost savings using Nol8.
- Nol8's technology addresses CPU bottlenecks in AI data processing.
- FortifAI Limited uses AI to enhance technology efficiencies and develop video games.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$17 |
Quarterly Report - Q3 FY26
|
28 Apr 2026 9:35AM |
$0.215 |
$0.185 |
fallen by
13.95%
|
|
NXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexsen ended the quarter with $5.73 million in cash reserves.
- Secured AU$500,000 grant for neonatal diagnostics and HK$6 million IGNITE Grant for Hong Kong expansion.
- StrepSure® test for Group B Streptococcus progressing towards FDA submission by Q4 2026.
- Global rollout strategy for StrepSure® targeting Hong Kong, Malaysia, and India.
- Advancing towards ISO 13485 certification to support regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Finder Energy Holdings Limited (FDR) ORDINARY FULLY PAID |
Energy |
$238 |
Trading Halt
|
28 Apr 2026 9:34AM |
$0.590 |
$0.475 |
fallen by
19.49%
|
|
FDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Finder Energy Holdings Limited.
- Trading halt is due to pending capital raising announcement.
- Halt in accordance with ASX Listing Rule 17.1.
- Expected to lift by normal trading on 30 April 2026.
- No known reason for halt not to be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xamble Group Limited (XGL) CHESS DEPOSITARY INTERESTS 1:1 |
Communication Services |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:34AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
XGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue was A$1.64 million in Q1 CY2026, a decrease of 1% compared to the previous year.
- Underlying business EBITDA loss was A$0.17 million, reflecting higher operating costs.
- The Group received an A$306,000 drawdown from the Malaysian Digital Acceleration Grant.
- Cash flow from operating activities was almost neutral with a slight outflow of A$12,000.
- Three new commercial contracts in technology, education, and automotive sectors valued at A$1.17 million.
- Completion of 55.6% acquisition of YouthsToday, expanding influencer community.
- Adrian Tan appointed as Interim CEO to lead integration and AI transformation.
- Stable cash and cash equivalents at A$946,000 with additional credit facility available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$15 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:33AM |
$0.485 |
$0.490 |
risen by
1.03%
|
|
OSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Q3 FY26 dose sales up 60% compared to the previous year.
- Number of commercially active treatment centres increased by 56% over the last year.
- Strategic initiatives expected to lower the cost base by $3.4-3.9 million annually from FY27.
- Germany G-BA Trial anticipated to start in Q4 FY26.
- Renzo DeCarlo appointed as Global Head of Manufacturing and Operations.
- Strong early clinical results in Türkiye with high surgical conversion rates.
- TRIPP-FFX Trial completed Last Patient, Last Visit (LPLV) with results expected in Q4 FY26.
- New manufacturing facility anticipated to be operational in 1H FY27.
- Comparative study shows survival and disease control benefits with OncoSil™ Therapy.
- $8 million capital raised and $1.8 million R&D tax incentive received.
- Strong cash position of $9.3 million as of 31 March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$90 |
LRT NAV Estimate - 24 April 2026
|
28 Apr 2026 9:32AM |
$2.280 |
$2.170 |
fallen by
4.82%
|
|
| Spheria Emerging Companies Limited (SEC) ORDINARY FULLY PAID |
Financials |
$145 |
Net Tangible Asset Backing
|
28 Apr 2026 9:32AM |
$2.390 |
$2.420 |
risen by
1.26%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$4 |
Change in substantial holding
|
28 Apr 2026 9:31AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$33 |
Quarterly Activities Report
|
28 Apr 2026 9:31AM |
$0.270 |
$0.255 |
fallen by
5.56%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drilling program commenced at Zaranou Gold Project in Côte d'Ivoire.
- Initial drilling results confirm mineralisation extends significantly deeper and remains open in multiple directions.
- Zaranou project holds an inferred resource of 364,600 ounces of gold.
- Skylark is also advancing exploration at Maphai and Vavoua projects.
- Company is actively seeking new asset opportunities in West Africa.
- Recent capital raise maintains strong cash position for exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$73 |
March 2026 Quarterly Activities and Cashflow Report
|
28 Apr 2026 9:31AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Gasaat Phosphate Project in Tunisia supported by local communities and government
- KM and SAB prospects show promising phosphate mineralization
- Operating cash outflows of $714,000 and investing outflows of $501,000
- Net inflow of $4.67 million from financing activities
- Project strategically significant due to high-quality phosphate resources and location
- Phosphate critical for agriculture and battery production
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomic Eagle Ltd (AEU) ORDINARY FULLY PAID |
Materials |
$139 |
Commencement of 30,000m drill program
|
28 Apr 2026 9:31AM |
$0.420 |
$0.365 |
fallen by
13.10%
|
|
AEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomic Eagle Limited's 2026 drill program commenced at its Muntanga Uranium Project in Zambia.
- The drilling program targets 30,000 meters across three key areas: Chisebuka, Namakande, and Muntanga North.
- The program aims to expand the uranium resource base and test new exploration targets.
- The company reported a 24% increase in its total Mineral Resources to 58.8 million pounds of U3O8.
- The Chisebuka area will undergo infill drilling to convert known mineralization into a JORC-compliant Mineral Resource.
- Namakande and Muntanga North will see maiden drilling to explore new potential uranium deposits.
- Atomic Eagle is fully funded for its exploration programs in 2026 and 2027.
- The exploration will support Atomic Eagle's vision of developing a district-scale uranium mine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cullen Resources Limited (CUL) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 9:30AM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
CUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities was negative $375,000 for the quarter.
- Proceeds from the sale of non-current assets totaled $1,500,000.
- Advances from directors provided a net cash inflow of $110,000, with repayments of $170,000.
- Cash and cash equivalents at the end of the period were $609,000.
- Payments to related parties during the quarter totaled $81,000.
- The company plans to continue drilling activities at the Yardilla Gold Project.
- An access agreement has been signed for exploration at the Marymia Inlier project.
- No proceeds were raised from equity securities or convertible debt securities during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$224 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 9:30AM |
$1.250 |
$1.150 |
fallen by
8%
|
|
HRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of deep diamond drilling at Kingfisher and Omega prospects.
- Initiation of resource expansion drilling at Eagle South and Goldfinch prospects.
- Advancement of the Gum Creek Feasibility Study, on schedule for H1 CY 2026.
- High-grade gold mineralization confirmed at Kingfisher.
- Capital raising of $30 million announced to support studies and exploration.
- Appointment of Scott Williamson as CEO and Managing Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$33 |
Quarterly Cashflow Report
|
28 Apr 2026 9:30AM |
$0.270 |
$0.255 |
fallen by
5.56%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities was $647,000 for the quarter.
- No receipts from customers were recorded.
- Significant cash outflows in staff and administration costs.
- Investing activities saw a $1,139,000 outflow for exploration.
- Net cash outflow from investing activities for the nine months was $7,669,000.
- Financing activities raised $6,427,000 primarily through equity issuance.
- Cash balance at end of the period increased to $7,531,000.
- Payments to related parties for the quarter were $149,000.
- Estimated 4.2 quarters of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| H3 Energy Limited (H3E) ORDINARY FULLY PAID |
Energy |
$9 |
Trading Halt
|
28 Apr 2026 9:29AM |
$0.010 |
$0.011 |
risen by
10%
|
|
H3E - Price-sensitive ASX Announcement
Full Release
Key Points
- H3 Energy Limited requested a trading halt on its shares.
- The halt is due to an upcoming announcement regarding Capital Raising.
- Trading halt remains until the announcement or 30 April 2026.
- The trading halt request is in accordance with ASX Listing Rule 17.1.
- Board of H3 Energy Limited approved the trading halt request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Entropy Neurodynamics Limited (ENP) ORDINARY FULLY PAID |
Health Care |
$60 |
Quarterly Activities Report and Appendix 4C
|
28 Apr 2026 9:29AM |
$0.035 |
$0.038 |
risen by
10.14%
|
|
ENP - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant progress in TRP-8803 clinical trial for Binge Eating Disorder.
- Completion of Phase 2 BED trial Cohort 1 enrollment.
- Publication of positive Phase 2a results for TRP-8802.
- Grant of Australian patent for IV dosing method valid until 2042.
- Financial position supported by R&D tax incentive and funding facilities.
- Net increase in cash and cash equivalents reported for the quarter.
- Focus on clinical execution and IP strengthening.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$28 |
Challenger Tax Liability and ADG Indemnity
|
28 Apr 2026 9:28AM |
$0.365 |
$0.405 |
risen by
10.96%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,767 |
Appendix 3C
|
28 Apr 2026 9:28AM |
$42.160 |
$42.515 |
risen by
0.84%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$32 |
Update - Notification of buy-back - KME
|
28 Apr 2026 9:27AM |
$0.580 |
$0.580 |
fallen by
0%
|
|
| Red Metal Limited (RDM) ORDINARY FULLY PAID |
Materials |
$56 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 9:27AM |
$0.155 |
$0.145 |
fallen by
6.45%
|
|
RDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Metal Limited's quarterly cash flow report indicates a net cash outflow of $720,000.
- Exploration costs were the primary reason for cash outflow.
- Exploration activities included the Sybella Rare Earth project and Pardoo and Pulkarrimarra projects.
- Cash and cash equivalents decreased to $4.314 million at the end of the quarter.
- An in-specie share distribution of Maronan Metals Limited is proposed.
- Government co-funding grants were secured for future exploration.
- No changes in joint venture interests were reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$13 |
Trading Halt
|
28 Apr 2026 9:27AM |
$0.023 |
$0.018 |
fallen by
21.74%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Godolphin Resources Limited (ASX: GRL) has requested a trading halt.
- The trading halt is for the purpose of executing a material placement.
- The halt will remain until an announcement is made or trading commences on 30 April 2026.
- Godolphin expects the halt to conclude with the announcement to the ASX.
- No reasons were identified by Godolphin for denying the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,767 |
Appendix 3C
|
28 Apr 2026 9:26AM |
$42.160 |
$42.515 |
risen by
0.84%
|
|
| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$1,622 |
Appendix 3Y - Alfie Grigg
|
28 Apr 2026 9:26AM |
$0.004 |
$0.004 |
risen by
14.29%
|
|
| Australis Oil and Gas Limited (ATS) ORDINARY FULLY PAID |
Energy |
$28 |
Quarterly Activities Report and Appendix 5B
|
28 Apr 2026 9:26AM |
$0.021 |
$0.020 |
fallen by
4.76%
|
|
ATS - Price-sensitive ASX Announcement
Full Release
Key Points
- Australis formed a partnership with a US-listed oil and gas company for TMS development.
- The partnership includes a US$46.25 million development program for new wells.
- Australis sold 90% of its working interest in TMS producing wells to EQV.
- Company maintains US$13.6 million in cash and cash equivalents as of March 31, 2026.
- Australis remains debt-free following repayment of Macquarie credit facilities in 2025.
- The report details cash flows with a net cash outflow from operations.
- Australis now participates at a 20% working interest in the Initial Leasing Program within the AMI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
